Home › Forums › Melanoma Diagnosis: Stage IV › GSK BRAF/MEK GIVEN SPEEDY APPROVAL PROCESS

  • This topic is empty.
Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • February 13, 2013 at 12:34 pm #21022
    Catherine Poole
    Keymaster

    It could be on the market in Europe within 6 months!

    http://www.pharmatimes.com/Article/13-02-12/GSK_granted_speedy_review_for_melanoma_drug.aspx

    Hope to hear something soon on FDA approval in the US

    February 13, 2013 at 4:27 pm #59161
    jmmm
    Participant

    That’s great news! When will it be available in the US? Is just the MEK inhibitor being approved, or both? Will patients be able to combine GSK’s MEK with Zelboraf, or will it have to be with GSK’s BRaf inhibitor? Sorry, lots of questions, but this is the place to get answers:)

    February 14, 2013 at 11:13 pm #59162
    Catherine Poole
    Keymaster

    should be approved soon in the U.S. but can’t say when. Both the BRAF and MEK agent will be approved. Whether they can be combined will be up to your doctor and also mixed with other agents. STay tuned..

  • Author
    Posts
Viewing 3 posts - 1 through 3 (of 3 total)
  • The forum ‘Melanoma Diagnosis: Stage IV’ is closed to new topics and replies.